Cutting edge: Antibody-dependent memory-like NK cells distinguished by FcRγ deficiency

Journal of Immunology

Volumn 190, Issue 4, 2013, Pages 1402-1406

  Zhang, Tianxiang ^a   Scott, Jeannine M ^a   Hwang, Ilwoong ^a   Kim, Sungjin ^a  

^a Michigan State University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD9 ANTIGEN; FC RECEPTOR; FC RECEPTOR GAMMA; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE; CELLS, CULTURED; CYTOMEGALOVIRUS; GENE TARGETING; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; RECEPTORS, IGG;

EID: 84873565353     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203034     Document Type: Article

References (25)

1. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
2. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
3. Etzioni, A., C. Eidenschenk, R. Katz, R. Beck, J. L. Casanova, and S. Pollack. 2005. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146: 423-425.
4. Kuijpers, T. W., P. A. Baars, C. Dantin, M. van den Burg, R. A. van Lier, and E. Roosnek. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
5. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, W. Müller, and J. P. Di Santo. 2003. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101: 4887-4893.
6. Jamieson, A. M., P. Isnard, J. R. Dorfman, M. C. Coles, and D. H. Raulet. 2004. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J. Immunol. 172: 864-870.
7. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T celland B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
8. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
9. Paust, S., H. S. Gill, B. Z. Wang, M. P. Flynn, E. A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P. W. Askenase, R. W. Compans, and U. H. von Andrian. 2010. Critical role for the chemokine receptor CXCR6 in NK cellmediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11: 1127-1135.
10. Cooper, M. A., and W. M. Yokoyama. 2010. Memory-like responses of natural killer cells. Immunol. Rev. 235: 297-305.
11. Hwang, I., T. Zhang, J. M. Scott, A. R. Kim, T. Lee, T. Kakarla, A. Kim, J. B. Sunwoo, and S. Kim. 2012. Identification of human NK cells that are deficient for signaling adaptor FcRg and specialized for antibody-dependent immune functions. Int. Immunol. 24: 793-802.
12. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502.
13. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
14. Moretta, L., C. Bottino, D. Pende, R. Castriconi, M. C.Mingari, and A. Moretta. 2006. Surface NK receptors and their ligands on tumor cells. Semin. Immunol. 18: 151-158.
15. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
16. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
17. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
18. Cha, T. A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70: 78-83.
19. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
20. +) natural killer cells. Hum. Immunol. 71: 29-35.
21. Cooper, M. A., J. E. Bush, T. A. Fehniger, J. B. VanDeusen, R. E. Waite, Y. Liu, H. L. Aguila, and M. A. Caligiuri. 2002. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 100: 3633-3638.
22. + T cells. J. Immunol. 164: 3950-3954.
23. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
24. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-529.
25. Schlub, T. E., J. C. Sun, S. M. Walton, S. H. Robbins, A. K. Pinto, M. W. Munks, A. B. Hill, L. Brossay, A. Oxenius, and M. P. Davenport. 2011. Comparing the kinetics of NK cells, CD4, and CD8 T cells in murine cytomegalovirus infection. J. Immunol. 187: 1385-1392.